Toggle navigation
Home
Feed
Channels
Profile
Home
Feed
Channels
Profile
Medspoke's Talks
Medspoke
Medspoke
BJU International
Published October 13, 2026
[18F]fluorodeoxyglucose PET/CT refines staging and treatment selection in high-risk upper tract u...
October 14, 2026
Medspoke
Medspoke
Clinical Cancer Research
Published October 13, 2026
00:00
--:--
Differential impact of tumor-derived ESR1 mutations on elacestrant benefit in metastatic breast c...
October 14, 2026
Share
Differential impact of tumor-derived ESR1 mutations on elacestrant benefit in metastatic breast cancer.
https://www.medspoke.co/channel_journal?id=686&tap_id=15577
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
Medspoke
Medspoke
Clinical Cancer Research
Published October 13, 2026
Cerebrospinal fluid and plasma circulating tumor DNA dynamics as a biomarker of response during t...
October 14, 2026
Why are you reporting this TALK?
